273 related articles for article (PubMed ID: 23047824)
1. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
Edelmann J; Holzmann K; Miller F; Winkler D; Bühler A; Zenz T; Bullinger L; Kühn MW; Gerhardinger A; Bloehdorn J; Radtke I; Su X; Ma J; Pounds S; Hallek M; Lichter P; Korbel J; Busch R; Mertens D; Downing JR; Stilgenbauer S; Döhner H
Blood; 2012 Dec; 120(24):4783-94. PubMed ID: 23047824
[TBL] [Abstract][Full Text] [Related]
2. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
[TBL] [Abstract][Full Text] [Related]
3. High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia.
Tyybakinoja A; Vilpo J; Knuutila S
Cytogenet Genome Res; 2007; 118(1):8-12. PubMed ID: 17901694
[TBL] [Abstract][Full Text] [Related]
4. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
Haslinger C; Schweifer N; Stilgenbauer S; Döhner H; Lichter P; Kraut N; Stratowa C; Abseher R
J Clin Oncol; 2004 Oct; 22(19):3937-49. PubMed ID: 15459216
[TBL] [Abstract][Full Text] [Related]
5. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
[TBL] [Abstract][Full Text] [Related]
6. High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.
Kühn MW; Radtke I; Bullinger L; Goorha S; Cheng J; Edelmann J; Gohlke J; Su X; Paschka P; Pounds S; Krauter J; Ganser A; Quessar A; Ribeiro R; Gaidzik VI; Shurtleff S; Krönke J; Holzmann K; Ma J; Schlenk RF; Rubnitz JE; Döhner K; Döhner H; Downing JR
Blood; 2012 Mar; 119(10):e67-75. PubMed ID: 22234698
[TBL] [Abstract][Full Text] [Related]
7. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
8. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.
Salaverria I; Martín-Garcia D; López C; Clot G; García-Aragonés M; Navarro A; Delgado J; Baumann T; Pinyol M; Martin-Guerrero I; Carrió A; Costa D; Queirós AC; Jayne S; Aymerich M; Villamor N; Colomer D; González M; López-Guillermo A; Campo E; Dyer MJ; Siebert R; Armengol L; Beà S
Genes Chromosomes Cancer; 2015 Nov; 54(11):668-80. PubMed ID: 26305789
[TBL] [Abstract][Full Text] [Related]
9. High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.
Marincevic M; Cahill N; Gunnarsson R; Isaksson A; Mansouri M; Göransson H; Rasmussen M; Jansson M; Ryan F; Karlsson K; Adami HO; Davi F; Jurlander J; Juliusson G; Stamatopoulos K; Rosenquist R
Haematologica; 2010 Sep; 95(9):1519-25. PubMed ID: 20421269
[TBL] [Abstract][Full Text] [Related]
10. Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
Mian M; Rinaldi A; Mensah AA; Rossi D; Ladetto M; Forconi F; Marasca R; Uhr M; Stussi G; Kwee I; Cavalli F; Gaidano G; Zucca E; Bertoni F
Ann Oncol; 2013 May; 24(5):1378-84. PubMed ID: 23372049
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
[TBL] [Abstract][Full Text] [Related]
12. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.
Schweighofer CD; Coombes KR; Majewski T; Barron LL; Lerner S; Sargent RL; O'Brien S; Ferrajoli A; Wierda WG; Czerniak BA; Medeiros LJ; Keating MJ; Abruzzo LV
J Mol Diagn; 2013 Mar; 15(2):196-209. PubMed ID: 23273604
[TBL] [Abstract][Full Text] [Related]
13. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
[TBL] [Abstract][Full Text] [Related]
15. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
[TBL] [Abstract][Full Text] [Related]
16. Genetic landscape of ultra-stable chronic lymphocytic leukemia patients.
Raponi S; Del Giudice I; Marinelli M; Wang J; Cafforio L; Ilari C; Piciocchi A; Messina M; Bonina S; Tavolaro S; Bordyuh M; Mariglia P; Peragine N; Mauro FR; Chiaretti S; Molica S; Gentile M; Visentin A; Trentin L; Rigolin GM; Cuneo A; Diop F; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
Ann Oncol; 2018 Apr; 29(4):966-972. PubMed ID: 29365086
[TBL] [Abstract][Full Text] [Related]
17. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
18. Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?
Puiggros A; Puigdecanet E; Salido M; Ferrer A; Abella E; Gimeno E; Nonell L; Herranz MJ; Galván AB; Rodríguez-Rivera M; Melero C; Pairet S; Bellosillo B; Serrano S; Florensa L; Solé F; Espinet B
Leuk Lymphoma; 2013 May; 54(5):986-95. PubMed ID: 22994157
[TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
20. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
Wang H; Xu H; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
